<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK470716" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK470716/" /><meta name="ncbi_pagename" content="Pelizaeus-Merzbacher-Like Disease 1 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Pelizaeus-Merzbacher-Like Disease 1 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Pelizaeus-Merzbacher-Like Disease 1" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/01/17" /><meta name="citation_author" content="Norah Nahhas" /><meta name="citation_author" content="Alex Conant" /><meta name="citation_author" content="Jennifer Orthmann-Murphy" /><meta name="citation_author" content="Adeline Vanderver" /><meta name="citation_author" content="Grace Hobson" /><meta name="citation_pmid" content="29276893" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK470716/" /><meta name="citation_keywords" content="Hypomyelinating Leukodystrophy 2 (HLD2)" /><meta name="citation_keywords" content="PMLD1" /><meta name="citation_keywords" content="PMLD1" /><meta name="citation_keywords" content="Hypomyelinating Leukodystrophy 2 (HLD2)" /><meta name="citation_keywords" content="Gap junction gamma-2 protein" /><meta name="citation_keywords" content="GJC2" /><meta name="citation_keywords" content="Pelizaeus-Merzbacher-Like Disease 1" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Pelizaeus-Merzbacher-Like Disease 1" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Norah Nahhas" /><meta name="DC.Contributor" content="Alex Conant" /><meta name="DC.Contributor" content="Jennifer Orthmann-Murphy" /><meta name="DC.Contributor" content="Adeline Vanderver" /><meta name="DC.Contributor" content="Grace Hobson" /><meta name="DC.Date" content="2019/01/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK470716/" /><meta name="description" content="Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents during the neonatal or early-infantile period with nystagmus, commonly associated with hypotonia, delayed acquisition of motor milestones, speech delay, and dysarthria. Over time the hypotonia typically evolves into spasticity that affects the ability to walk and communicate. Cerebellar signs (gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia) frequently manifest during childhood. Some individuals develop extrapyramidal movement abnormalities (choreoathetosis and dystonia). Hearing loss and optic atrophy are observed in rare cases. Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis. Most individuals have normal cognitive skills or mild intellectual disability – which, however, can be difficult to evaluate in the context of profound motor impairment." /><meta name="og:title" content="Pelizaeus-Merzbacher-Like Disease 1" /><meta name="og:type" content="book" /><meta name="og:description" content="Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents during the neonatal or early-infantile period with nystagmus, commonly associated with hypotonia, delayed acquisition of motor milestones, speech delay, and dysarthria. Over time the hypotonia typically evolves into spasticity that affects the ability to walk and communicate. Cerebellar signs (gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia) frequently manifest during childhood. Some individuals develop extrapyramidal movement abnormalities (choreoathetosis and dystonia). Hearing loss and optic atrophy are observed in rare cases. Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis. Most individuals have normal cognitive skills or mild intellectual disability – which, however, can be difficult to evaluate in the context of profound motor impairment." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK470716/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pmld1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK470716/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A3D94E0402D1100000000044A0183.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK470716_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK470716_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/parkinson-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pendred/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK470716_"><span class="title" itemprop="name">Pelizaeus-Merzbacher-Like Disease 1</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Hypomyelinating Leukodystrophy 2 (HLD2), PMLD1</div><p class="contrib-group"><span itemprop="author">Norah Nahhas</span>, MD, <span itemprop="author">Alex Conant</span>, BS, <span itemprop="author">Jennifer Orthmann-Murphy</span>, MD, PhD, <span itemprop="author">Adeline Vanderver</span>, MD, and <span itemprop="author">Grace Hobson</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK470716_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK470716_ai__"><div class="contrib half_rhythm"><span itemprop="author">Norah Nahhas</span>, MD<div class="affiliation small">Children&#x02019;s National Health System<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.lanoitansnerdlihc@sahhann" class="oemail">gro.lanoitansnerdlihc@sahhann</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alex Conant</span>, BS<div class="affiliation small">Children&#x02019;s National Health System<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.lanoitansnerdlihc@tnanoca" class="oemail">gro.lanoitansnerdlihc@tnanoca</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer Orthmann-Murphy</span>, MD, PhD<div class="affiliation small">John Hopkins University<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imhj@1amhtroj" class="oemail">ude.imhj@1amhtroj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Adeline Vanderver</span>, MD<div class="affiliation small">Children&#x02019;s National Health System<br />Washington, DC</div><div class="affiliation small">Children&#x02019;s Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmnc@vrednava" class="oemail">gro.cmnc@vrednava</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ude.pohc.liame@arevrednav" class="oemail">ude.pohc.liame@arevrednav</a><div></div></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Grace Hobson</span>, PhD<div class="affiliation small">Nemours Alfred I duPont Hospital for Children<br />Wilmington, Delaware<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.sruomen@nosbohg" class="oemail">gro.sruomen@nosbohg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 21, 2017</span>; Last Revision: <span itemprop="dateModified">January 17, 2019</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pmld1.Summary" itemprop="description"><h2 id="_pmld1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents during the neonatal or early-infantile period with nystagmus, commonly associated with hypotonia, delayed acquisition of motor milestones, speech delay, and dysarthria. Over time the hypotonia typically evolves into spasticity that affects the ability to walk and communicate. Cerebellar signs (gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia) frequently manifest during childhood. Some individuals develop extrapyramidal movement abnormalities (choreoathetosis and dystonia). Hearing loss and optic atrophy are observed in rare cases. Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis. Most individuals have normal cognitive skills or mild intellectual disability &#x02013; which, however, can be difficult to evaluate in the context of profound motor impairment.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of PMLD1 is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and neuroimaging findings and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GJC2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> To date no definite treatment is available; treatment is mainly supportive and includes assuring adequate nutrition and providing standard treatment for developmental delay/cognitive impairment, neurologic complications (spasticity, ataxia, epilepsy, extrapyramidal movement disorders), communication difficulties, hearing loss, and visual impairment.</p><p><i>Surveillance:</i> Routine assessment of growth, weight gain, vision, and hearing. Routine monitoring of disease progression, spine for evidence of scoliosis and hips for evidence of dislocation, and needs related to physical therapy, communication, and swallowing/feeding.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>PMLD1 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>), and a 25% chance of being unaffected and not a carrier. Once the <i>GJC2</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="pmld1.Diagnosis"><h2 id="_pmld1_Diagnosis_">Diagnosis</h2><div id="pmld1.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Pelizaeus-Merzbacher-like disease 1 (PMLD1) <b>should be suspected</b> in individuals with the following classic clinical and neuroimaging findings:</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Nystagmus that typically presents during the neonatal period or early infancy</div></li><li class="half_rhythm"><div>Mainly motor developmental delay and central hypotonia during infancy</div></li><li class="half_rhythm"><div>Signs of upper motor neuron dysfunction (including spasticity, brisk deep tendon reflexes, and Babinski sign) usually affecting the lower limbs more than the upper limbs</div></li><li class="half_rhythm"><div>Gait ataxia and other cerebellar signs</div></li><li class="half_rhythm"><div>Mild choreiform movements and dystonia of the extremities that can become severe and disabling</div></li><li class="half_rhythm"><div>Dysarthria and swallowing dysfunction</div></li></ul><p><b>Neuroimaging findings.</b> Findings on brain MRI include the following [<a class="bk_pop" href="#pmld1.REF.bugiani.2006.273">Bugiani et al 2006</a>, <a class="bk_pop" href="#pmld1.REF.steenweg.2010.2971">Steenweg et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.parikh.2015.501">Parikh et al 2015</a>] (see <a class="figpopup" href="/books/NBK470716/figure/pmld1.F1/?report=objectonly" target="object" rid-figpopup="figpmld1F1" rid-ob="figobpmld1F1">Figure 1</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpmld1F1" co-legend-rid="figlgndpmld1F1"><a href="/books/NBK470716/figure/pmld1.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figpmld1F1" rid-ob="figobpmld1F1"><img class="small-thumb" src="/books/NBK470716/bin/pmld1-Image001.gif" src-large="/books/NBK470716/bin/pmld1-Image001.jpg" alt="Figure 1. . MRI in a male age 36 months with molecularly confirmed PMLD1." /></a><div class="icnblk_cntnt" id="figlgndpmld1F1"><h4 id="pmld1.F1"><a href="/books/NBK470716/figure/pmld1.F1/?report=objectonly" target="object" rid-ob="figobpmld1F1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">MRI in a male age 36 months with molecularly confirmed PMLD1. Note the diffuse T<sub>2</sub>-weighted hyperintensity (A and B) and diffuseT<sub>1</sub> mild hyperintensity (C and D) consistent with hypomyelination. Involvement of pontine structures is seen in A (axial view) <a href="/books/NBK470716/figure/pmld1.F1/?report=objectonly" target="object" rid-ob="figobpmld1F1">(more...)</a></p></div></div><ul><li class="half_rhythm"><div>Diffuse homogeneous hyperintense T<sub>2</sub>-weighted signal that affects the white matter of the cerebrum and cerebellum</div></li><li class="half_rhythm"><div>Involvement of the corticospinal tracts with abnormal T<sub>2</sub>-weighted signal extending into the brain stem resulting in extensive brain stem involvement not typically seen in Pelizaeus-Merzbacher disease (see <a href="#pmld1.Differential_Diagnosis">Differential Diagnosis</a>)</div></li><li class="half_rhythm"><div>Thin corpus callosum in older children</div></li><li class="half_rhythm"><div>Brain atrophy and ventricular dilatation as a consequence of white matter loss without specific cerebellar atrophy [<a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2009.426">Orthmann-Murphy et al 2009</a>]</div></li><li class="half_rhythm"><div>Relative preservation of deep gray nuclei and the thalami</div></li></ul></div><div id="pmld1.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of PMLD1 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a href="#pmld1.Suggestive_Findings">suggestive clinical and neuroimaging findings</a> and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GJC2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK470716/table/pmld1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figpmld1Tmoleculargenetictestingusedi" rid-ob="figobpmld1Tmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of PMLD1 is broad, children with the distinctive findings described in <a href="#pmld1.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#pmld1.Option_1">Option 1</a>), whereas those with a mild phenotype indistinguishable from many other inherited leukodystrophies are more likely to be diagnosed using genomic testing (see <a href="#pmld1.Option_2">Option 2</a>).</p><div id="pmld1.Option_1"><h4>Option 1</h4><p>When the clinical findings and brain MRI findings suggest the diagnosis of a PMLD1, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>GJC2</i>, including the noncoding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 (see Note), is performed first. If only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</div><div class="half_rhythm">Note: Two variants in the noncoding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1, <a class="figpopup" href="/books/NBK470716/table/pmld1.T.gjc2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figpmld1Tgjc2pathogenicvariantsdiscuss" rid-ob="figobpmld1Tgjc2pathogenicvariantsdiscuss">c.-170A&#x0003e;G</a> and <a class="figpopup" href="/books/NBK470716/table/pmld1.T.gjc2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figpmld1Tgjc2pathogenicvariantsdiscuss" rid-ob="figobpmld1Tgjc2pathogenicvariantsdiscuss">c.-167A&#x0003e;G</a>, have been frequently associated with disease and should be included in sequencing assays [<a class="bk_pop" href="#pmld1.REF.osaka.2010.250">Osaka et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.meyer.2011.637">Meyer et al 2011</a>, <a class="bk_pop" href="#pmld1.REF.combes.2012.146">Combes et al 2012</a>, <a class="bk_pop" href="#pmld1.REF.kammoun_jellouli.2013.233">Kammoun Jellouli et al 2013</a>, <a class="bk_pop" href="#pmld1.REF.gotoh.2014.393">Gotoh et al 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GJC2</i> and other genes of interest (see <a href="#pmld1.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK470716/table/pmld1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figpmld1Tmoleculargenetictestingusedi" rid-ob="figobpmld1Tmoleculargenetictestingusedi">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="pmld1.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited leukodystrophies, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) or <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available). Comprehensive genomic testing includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="pmld1.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Pelizaeus-Merzbacher-Like Disease 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJC2</i></td><td headers="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Sequence analysis including promoter regions (first <i>GJC2</i> noncoding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>)&#x000a0;<sup>3</sup></td><td headers="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">53/79&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_pmld1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">26/79&#x000a0;<sup>4,&#x000a0;5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pmld1.TF.1.1"><p class="no_margin">See <a href="/books/NBK470716/#pmld1.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="pmld1.TF.1.2"><p class="no_margin">See <a href="#pmld1.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="pmld1.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="pmld1.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#pmld1.REF.uhlenberg.2004.251">Uhlenberg et al [2004]</a>, <a class="bk_pop" href="#pmld1.REF.bugiani.2006.273">Bugiani et al [2006]</a>, <a class="bk_pop" href="#pmld1.REF.wolf.2007.39">Wolf et al [2007]</a>, <a class="bk_pop" href="#pmld1.REF.henneke.2008.748">Henneke et al [2008]</a>, <a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2009.426">Orthmann-Murphy et al [2009]</a>, <a class="bk_pop" href="#pmld1.REF.wang.2010.236">Wang et al [2010]</a>, <a class="bk_pop" href="#pmld1.REF.zittel.2012.2498">Zittel et al [2012]</a>, <a class="bk_pop" href="#pmld1.REF.alyahyaee.2013.1467">Al-Yahyaee et al [2013]</a>, <a class="bk_pop" href="#pmld1.REF.biancheri.2013.34">Biancheri et al [2013]</a>, <a class="bk_pop" href="#pmld1.REF.shimojima.2013.123">Shimojima et al [2013]</a>, <a class="bk_pop" href="#pmld1.REF.abrams.2014.1929">Abrams et al [2014]</a></p></div></dd><dt>5. </dt><dd><div id="pmld1.TF.1.5"><p class="no_margin">Twenty-two of 51 reported <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had pathogenic variants in the noncoding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 of <i>GJC2</i>: <a class="figpopup" href="/books/NBK470716/table/pmld1.T.gjc2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figpmld1Tgjc2pathogenicvariantsdiscuss" rid-ob="figobpmld1Tgjc2pathogenicvariantsdiscuss">c.-170A&#x0003e;G</a> in two individuals and <a class="figpopup" href="/books/NBK470716/table/pmld1.T.gjc2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figpmld1Tgjc2pathogenicvariantsdiscuss" rid-ob="figobpmld1Tgjc2pathogenicvariantsdiscuss">c.-167A&#x0003e;G</a> in 20 individuals [<a class="bk_pop" href="#pmld1.REF.osaka.2010.250">Osaka et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.meyer.2011.637">Meyer et al 2011</a>, <a class="bk_pop" href="#pmld1.REF.combes.2012.146">Combes et al 2012</a>, <a class="bk_pop" href="#pmld1.REF.kammoun_jellouli.2013.233">Kammoun Jellouli et al 2013</a>, <a class="bk_pop" href="#pmld1.REF.gotoh.2014.393">Gotoh et al 2014</a>]; thus, it is important that this noncoding exon be included in <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></div></dd><dt>6. </dt><dd><div id="pmld1.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="pmld1.Clinical_Characteristics"><h2 id="_pmld1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pmld1.Clinical_Description"><h3>Clinical Description</h3><p>Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents in the neonatal period or early infancy with nystagmus, often complicated by hypotonia and developmental delay. Over time the hypotonia may evolve into spasticity, and extrapyramidal movement abnormalities may emerge. Older children often manifest significant motor impairments that can also effect communication. Cognition is relatively preserved. The following detailed description of clinical manifestations is based on findings in individuals with a molecularly proven diagnosis [<a class="bk_pop" href="#pmld1.REF.uhlenberg.2004.251">Uhlenberg et al 2004</a>, <a class="bk_pop" href="#pmld1.REF.bugiani.2006.273">Bugiani et al 2006</a>, <a class="bk_pop" href="#pmld1.REF.wolf.2007.39">Wolf et al 2007</a>, <a class="bk_pop" href="#pmld1.REF.henneke.2008.748">Henneke et al 2008</a>, <a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2009.426">Orthmann-Murphy et al 2009</a>, <a class="bk_pop" href="#pmld1.REF.wang.2010.236">Wang et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.zittel.2012.2498">Zittel et al 2012</a>, <a class="bk_pop" href="#pmld1.REF.alyahyaee.2013.1467">Al-Yahyaee et al 2013</a>, <a class="bk_pop" href="#pmld1.REF.biancheri.2013.34">Biancheri et al 2013</a>, <a class="bk_pop" href="#pmld1.REF.shimojima.2013.123">Shimojima et al 2013</a>, <a class="bk_pop" href="#pmld1.REF.abrams.2014.1929">Abrams et al 2014</a>].</p><p>Nystagmus (either rotatory or horizontal) appears in early infancy and is not present in all individuals.</p><p>During later infancy, signs of central hypotonia and delayed acquisition of motor milestones become more apparent, with most children having speech delay and dysarthria as well.</p><p>Over time, progressive pyramidal tract involvement (manifest as spasticity, brisk deep tendon reflexes, and bilateral Babinski signs) affects the ability to walk. The lower limbs are often more involved than in the upper limbs. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children become wheelchair dependent in their first decade.</p><p>Cerebellar signs including gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia frequently manifest during childhood.</p><p>Some develop extrapyramidal movement disorders (choreoathetosis and dystonia), which may contribute to the functional disability.</p><p>Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis.</p><p>Cognitive function is relatively preserved: Most individuals have normal cognitive skills or mild intellectual disability that may be difficult to evaluate in the context of profound motor impairment. Dysarthria may severely impair communication in adolescents and young adults.</p><p>Other less common findings:</p><ul><li class="half_rhythm"><div>Seizures that are typically infrequent and responsive to antiepileptic drugs</div></li><li class="half_rhythm"><div>Sensorineural hearing loss [<a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2009.426">Orthmann-Murphy et al 2009</a>]</div></li><li class="half_rhythm"><div>Optic atrophy [<a class="bk_pop" href="#pmld1.REF.bugiani.2006.273">Bugiani et al 2006</a>]</div></li></ul><p>Onset is typically in infancy. Although connatal onset is thought to be very rare, one neonate with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nystagmus and severe neurologic impairment has been reported [<a class="bk_pop" href="#pmld1.REF.biancheri.2013.34">Biancheri et al 2013</a>]. Brain MRI revealed extensive white matter involvement and abnormal cervical spine white matter.</p><p><b>Neurophysiologic findings</b> [<a class="bk_pop" href="#pmld1.REF.henneke.2010.1785">Henneke et al 2010</a>]</p><p>The following can be normal or delayed:</p><ul><li class="half_rhythm"><div>Visual evoked potentials</div></li><li class="half_rhythm"><div>Brain stem auditory evoked potential</div></li><li class="half_rhythm"><div>Somatosensory evoked potential</div></li><li class="half_rhythm"><div>Nerve conduction studies [<a class="bk_pop" href="#pmld1.REF.uhlenberg.2004.251">Uhlenberg et al 2004</a>]</div></li></ul><p>Electromyogram is usually normal.</p><p>Electroencephalography shows nonspecific findings or occasionally (multi)focal epileptiform activity.</p></div><div id="pmld1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed with recurrent pathogenic variants.</p></div><div id="pmld1.Prevalence"><h3>Prevalence</h3><p>The disease prevalence is not known.</p></div></div><div id="pmld1.Genetically_Related_Allelic_Disord"><h2 id="_pmld1_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><div id="pmld1.T.allelic_disorders" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.allelic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pmld1.T.allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_pmld1.T.allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype&#x000a0;<sup>1</sup></th><th id="hd_h_pmld1.T.allelic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJC2</i></td><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hereditary lymphedema type IC (OMIM <a href="http://omim.org/entry/613480" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613480</a>)&#x000a0;<sup>2</sup></td><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Spastic paraplegia 44 (see <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>)&#x000a0;<sup>3</sup></td><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Subclinical leukodystrophy [<a class="bk_pop" href="#pmld1.REF.abrams.2014.1929">Abrams et al 2014</a>]&#x000a0;<sup>4</sup></td><td headers="hd_h_pmld1.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="pmld1.TF.2.1"><p class="no_margin">See hyperlinked <i>GeneReview</i>, OMIM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> entry, or cited reference for more information.</p></div></dd><dt>2. </dt><dd><div id="pmld1.TF.2.2"><p class="no_margin">Heterozygous <i>GJC2</i> pathogenic variants cause hereditary lymphedema type IC [<a class="bk_pop" href="#pmld1.REF.ferrell.2010.943">Ferrell et al 2010</a>]. It is not yet clear how <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>GJC2</i> may lead to disruption of lymphatic function.</p></div></dd><dt>3. </dt><dd><div id="pmld1.TF.2.3"><p class="no_margin">Three individuals with adulthood-onset <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> spastic paraplegia [<a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2009.426">Orthmann-Murphy et al 2009</a>]</p></div></dd><dt>4. </dt><dd><div id="pmld1.TF.2.4"><p class="no_margin">One individual with subtle changes on brain MRI and subclinical leukodystrophy (episodes of loss of consciousness associated with loss of bowel and bladder control) [<a class="bk_pop" href="#pmld1.REF.abrams.2014.1929">Abrams et al 2014</a>]</p></div></dd></dl></div></div></div></div><div id="pmld1.Differential_Diagnosis"><h2 id="_pmld1_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/pmd/"><b>Pelizaeus-Merzbacher disease</b></a>
<b>(PMD)</b> is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PLP1</i>. The clinical presentation and radiologic appearance are similar to PMLD1. Most individuals present with neonatal nystagmus, hypotonia, global developmental delay, spasticity, gait ataxia, and choreoathetosis. Diffuse hypomyelination on brain MRI is observed in most individuals. Note that MRI evidence of brain stem involvement is more characteristic of PMLD1 than PMD. Both PMD and PMLD1 can present as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> spastic paraparesis; see <a href="#pmld1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>.</p><p><b>Hypomyelination with atrophy of the basal ganglia and cerebellum</b> (see <a href="/books/n/gene/tubb4a-leuk/"><i>TUBB4A</i>-Related Leukodystrophy</a>) is caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TUBB4A</i>; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are typically <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family). Presentation is generally during infancy or early childhood with findings that overlap with PMLD1: psychomotor developmental delay, pyramidal signs, cerebellar signs, gait ataxia, extrapyramidal symptoms, and dysarthria. MRI demonstrates diffuse hypomyelination of the white matter typically associated with basal ganglia and cerebellar atrophy [<a class="bk_pop" href="#pmld1.REF.simons.2013.767">Simons et al 2013</a>].</p><p><b>4H syndrome</b> (hypomyelination, hypodontia, and hypogonadotropic hypogonadism syndrome) (see <a href="/books/n/gene/pol3-leuk/"><i>POLR3</i>-Related Leukodystrophy</a>) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>POLR1C</i>, <i>POLR3A</i>, and <i>POLR3B</i>. 4H syndrome presents with a combination of motor findings (spasticity, gait ataxia and cerebellar tremor, extrapyramidal movement disorders, and generally mild spasticity) that are similar to those of PMLD1. Additional findings are abnormal dentition, severe myopia, and hypogonadotropic hypogonadism, which are not observed in PMLD1.</p><p>See also <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>.</p></div><div id="pmld1.Management"><h2 id="_pmld1_Management_">Management</h2><div id="pmld1.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Pelizaeus-Merzbacher-like disease 1 (PMLD1), the evaluations summarized in <a class="figpopup" href="/books/NBK470716/table/pmld1.T.recommended_evaluations_followin/?report=objectonly" target="object" rid-figpopup="figpmld1Trecommendedevaluationsfollowin" rid-ob="figobpmld1Trecommendedevaluationsfollowin">Table 3</a> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p><div id="pmld1.T.recommended_evaluations_followin" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of Pelizaeus-Merzbacher-Like Disease 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.recommended_evaluations_followin/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.recommended_evaluations_followin_lrgtbl__"><table><thead><tr><th id="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Organ System</th><th id="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for optic atrophy &#x00026; nystagmus</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT</b></td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiology</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for sensorineural hearing loss</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a gastroenterologist</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consideration of swallowing study to assess for swallowing dysfunction &#x00026; management of constipation &#x00026; gastroesophageal reflux</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to an orthopedic surgeon for tone management or orthopedic complications as indicated</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examination to assess for evidence of hip dislocation, joint contractures, &#x00026; scoliosis</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a pediatric neurologist</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation of movement disorders, tone &#x00026; seizures</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a nutritionist</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of nutritional status &#x00026; needs</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a developmental specialist</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of developmental level &#x00026; needs for supportive therapies</td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a clinical geneticist and/or genetic counselor</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation of underlying diagnosis &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a></td></tr><tr><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a rehabilitation specialist</td><td headers="hd_h_pmld1.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of functional disability &#x00026; equipment needs/adjustments</td></tr></tbody></table></div></div></div><div id="pmld1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>There is no curative treatment for PMLD1; measures that can be taken to improve the individual's quality of life are summarized in <a class="figpopup" href="/books/NBK470716/table/pmld1.T.treatment_of_manifestations_in_i/?report=objectonly" target="object" rid-figpopup="figpmld1Ttreatmentofmanifestationsini" rid-ob="figobpmld1Ttreatmentofmanifestationsini">Table 4</a> [<a class="bk_pop" href="#pmld1.REF.van_haren.2015.516">Van Haren et al 2015</a>].</p><div id="pmld1.T.treatment_of_manifestations_in_i" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Pelizaeus-Merzbacher-Like Disease 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.treatment_of_manifestations_in_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.treatment_of_manifestations_in_i_lrgtbl__"><table><thead><tr><th id="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation</th><th id="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental</b><br /><b>delay &#x00026; cognitive</b><br /><b>dysfunction</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Accommodations in a special classroom setting or w/an aide</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Recommendations from a pediatric neurologist may be necessary to achieve maximum intellectual &#x00026; functional abilities.</td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spasticity</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral GABA agonists (e.g., baclofen, diazepam)</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For more focal spasticity, consider intramuscular injection of botulinum toxin.</td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Physical therapy</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">The use of equipment such as walker &#x00026; wheelchair</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dystonia</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">When associated w/spasticity, management of dystonia w/baclofen or intramuscular botulinum toxin;<br />trihexyphenidyl or tetrabenazine potentially helpful</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In many cases, dystonia is refractory to medical management.</td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis &#x00026;</b><br /><b>joint dislocation</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Management or surgical intervention by an orthopedist</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Swallowing</b><br /><b>dysfunction</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider swallowing evaluation &#x00026; feeding therapy</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Affected individuals are at risk of aspiration.</td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Nutrition plan &#x00026; possible supportive feeding device to avoid malnutrition</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysarthria</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider speech therapy to improve communication abilities</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Augmentative communication approaches are often necessary.</td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard antiepileptic drug therapy</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard approaches to hearing loss incl augmentative communication approaches; no evidence exists for cochlear implants in this context</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>.</td></tr><tr><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Optic atrophy</b></td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Supportive approaches for the vision-impaired individual</td><td headers="hd_h_pmld1.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="pmld1.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><div id="pmld1.T.prevention_of_secondary_complica" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Prevention of Secondary Complications in Individuals with Pelizaeus-Merzbacher-Like Disease 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.prevention_of_secondary_complica/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.prevention_of_secondary_complica_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complication</th><th id="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Preventive Measure</th><th id="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constipation</b></td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dietary management, laxatives, stool softeners</td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Bone health</b></td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular monitoring of serum vitamin D &#x00026; calcium levels</td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If osteopenia is documented, consult w/a bone health clinic to consider measures to avoid fracture.</td></tr><tr><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Community-</b><br /><b>acquired</b><br /><b>pneumonia</b></td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Good hand hygiene; influenza &#x00026; pneumococcal vaccines</td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are reported to have deterioration of neurologic function w/febrile illness &#x00026; infection&#x000a0;<sup>1</sup>.</td></tr><tr><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychosocial</b><br /><b>consequences</b><br /><b>in caregiver</b></td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Involvement of a social worker</td><td headers="hd_h_pmld1.T.prevention_of_secondary_complica_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pmld1.TF.5.1"><p class="no_margin"><a class="bk_pop" href="#pmld1.REF.bugiani.2006.273">Bugiani et al [2006]</a>, <a class="bk_pop" href="#pmld1.REF.meyer.2011.637">Meyer et al [2011]</a></p></div></dd></dl></div></div></div></div><div id="pmld1.Surveillance"><h3>Surveillance</h3><div id="pmld1.T.recommended_surveillance_for_ind" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Pelizaeus-Merzbacher-Like Disease 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.recommended_surveillance_for_ind/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.recommended_surveillance_for_ind_lrgtbl__"><table><thead><tr><th id="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Organ System</th><th id="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Frequency/Comment</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring of general health &#x00026; growth; immunizations</td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology</td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biannually unless symptoms develop</td></tr><tr><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pediatric neurology assessment for disease progression, symptom control, &#x00026; review of medications</td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physiatrist &#x00026; physical/occupational therapy assessments for functional capacity &#x00026; equipment needs</td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually w/more frequent treatment visits once evaluation completed</td></tr><tr><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Assessment of communication abilities</td><td headers="hd_h_pmld1.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr></tbody></table></div></div></div><div id="pmld1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#pmld1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pmld1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="pmld1.Genetic_Counseling"><h2 id="_pmld1_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pmld1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Pelizaeus-Merzbacher-like disease 1 (PMLD1) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="pmld1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are typically obligate heterozygotes (carriers of one <i>GJC2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with childhood-onset presentation of PMLD1 are not known to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) of a <i>GJC2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="pmld1.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>GJC2</i> pathogenic variants in the family.</p></div><div id="pmld1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pmld1.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>GJC2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="pmld1.Resources"><h2 id="_pmld1_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for Pelizaeus-Merzbacher-Like Disease 1 have been identified by <i>GeneReviews</i> staff.</p></div><div id="pmld1.Molecular_Genetics"><h2 id="_pmld1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pmld1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Pelizaeus-Merzbacher-Like Disease 1: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pmld1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pmld1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pmld1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pmld1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pmld1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pmld1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pmld1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57165" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GJC2</i></a></td><td headers="hd_b_pmld1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57165" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q42<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_pmld1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5T442" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Gap junction gamma-2 protein</a></td><td headers="hd_b_pmld1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/GJC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GJC2 database</a></td><td headers="hd_b_pmld1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GJC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GJC2</a></td><td headers="hd_b_pmld1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GJC2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GJC2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pmld1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pmld1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Pelizaeus-Merzbacher-Like Disease 1 (<a href="/omim/608803,608804" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608803" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608803</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GAP JUNCTION PROTEIN, GAMMA-2; GJC2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608804" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608804</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>GJC2</i> (previously known as <i>GJA12</i>) comprises two exons. The first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> is noncoding and contains the binding site for transcriptional factors; the second contains part of the 5&#x02032; UTR, the coding sequence, and the 3&#x02032; UTR. See <a href="/books/NBK470716/#pmld1.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK470716/table/pmld1.T.gjc2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figpmld1Tgjc2pathogenicvariantsdiscuss" rid-ob="figobpmld1Tgjc2pathogenicvariantsdiscuss">Table 7</a>.</p><div id="pmld1.T.gjc2_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p><i>GJC2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK470716/table/pmld1.T.gjc2_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pmld1.T.gjc2_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-167A&#x0003e;G<br />(-7899A&#x0003e;G relative to initiation codon)&#x000a0;<sup>2</sup></td><td headers="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020435.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020435<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-170A&#x0003e;G<br />(-7902A&#x0003e;G relative to initiation codon)&#x000a0;<sup>3</sup></td><td headers="hd_h_pmld1.T.gjc2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="pmld1.TF.7.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="pmld1.TF.7.2"><p class="no_margin"><a class="bk_pop" href="#pmld1.REF.osaka.2010.250">Osaka et al [2010]</a></p></div></dd><dt>3. </dt><dd><div id="pmld1.TF.7.3"><p class="no_margin"><a class="bk_pop" href="#pmld1.REF.gotoh.2014.393">Gotoh et al [2014]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>GJC2</i> encodes the gap junction gamma-2 protein, a 439-amino acid protein referred to as connexin 47 (Cx47), which is a member of the connexin family of highly conserved integral membrane proteins [<a class="bk_pop" href="#pmld1.REF.schlierf.2006.11">Schlierf et al 2006</a>, <a class="bk_pop" href="#pmld1.REF.wang.2010.236">Wang et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.gotoh.2014.393">Gotoh et al 2014</a>]. Cx47 is highly expressed in the brain and spinal cord, specifically in oligodendrocytes [<a class="bk_pop" href="#pmld1.REF.odermatt.2003.4549">Odermatt et al 2003</a>, <a class="bk_pop" href="#pmld1.REF.menichella.2006.10984">Menichella et al 2006</a>].</p><p>Connexins form complex intercellular channels called gap junctions between adjacent cell membranes [<a class="bk_pop" href="#pmld1.REF.willecke.2002.725">Willecke et al 2002</a>]. Gap junction channels enable coupling between adjacent oligodendrocytes, as well as with astrocytes, forming a glial syncytium [<a class="bk_pop" href="#pmld1.REF.rash.2001.1983">Rash et al 2001</a>, <a class="bk_pop" href="#pmld1.REF.maglione.2010.1104">Maglione et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.wasseff.2011.506">Wasseff &#x00026; Scherer 2011</a>]. Because astrocytes express connexin proteins (Cx43 and Cx30) that differ from those of oligodendrocytes (Cx47 and Cx32), the gap junction channels between astrocytes and oligodendrocytes are necessarily heterotypic (i.e., Cx47/Cx43 and Cx32/Cx30), whereas the gap junction channels between adjacent oligodendrocytes are likely homotypic (i.e., Cx47/Cx47 and Cx32/Cx32) [<a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2007.13949">Orthmann-Murphy et al 2007</a>].</p><p>Gap junctions enable the transfer of ions and small molecules between adjacent cells. The function of oligodendrocyte/astrocyte coupling in particular is unknown but appears to be critical for proper myelin formation and maintenance.</p><p>Mice that do not express Cx47 have a normal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, but have evidence of disrupted myelin (vacuole formation) on pathology. Mice deficient for both oligodendrocyte connexins (Cx47 and Cx32) exhibit a severe phenotype, characterized by seizures, tremor, and development of widespread vacuolated myelin on pathology [<a class="bk_pop" href="#pmld1.REF.menichella.2006.10984">Menichella et al 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pelizaeus-Merzbacher-like disease 1 (PMLD1)-associated <i>GJC2</i> pathogenic variants result in loss of function of Cx47 [<a class="bk_pop" href="#pmld1.REF.uhlenberg.2004.251">Uhlenberg et al 2004</a>, <a class="bk_pop" href="#pmld1.REF.diekmann.2010.985">Diekmann et al 2010</a>, <a class="bk_pop" href="#pmld1.REF.kim.2013.249">Kim et al 2013</a>] which either fails to properly localize to the cell surface or mislocalizes to the endoplasmic reticulum [<a class="bk_pop" href="#pmld1.REF.orthmannmurphy.2007.13949">Orthmann-Murphy et al 2007</a>]. The proteins of selected <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants had apparently normal location and distribution in gap-junction-deficient model cells, but showed no electric coupling in either the homopolymeric gap junction channel (Cx47/Cx47) or the heteropolymeric gap junction channel (Cx47/Cx43) [<a class="bk_pop" href="#pmld1.REF.kim.2013.249">Kim et al 2013</a>].</p><p>In a mouse model system, <a class="bk_pop" href="#pmld1.REF.tress.2011.e1002146">Tress et al [2011]</a> showed that rather than dysfunctional Cx47, the critical outcome of PMLD1-associated <i>GJC2</i> pathogenic variants was a decreased number of cells coupled within glial networks.</p></div><div id="pmld1.References"><h2 id="_pmld1_References_">References</h2><div id="pmld1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.abrams.2014.1929">Abrams CK, Scherer SS, Flores-Obando R, Freidin MM, Wong S, Lamantea E, Farina L, Scaioli V, Pareyson D, Salsano E. A new mutation in GJC2 associated with subclinical leukodystrophy. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:1929–38.</span> [<a href="/pmc/articles/PMC4301586/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4301586</span></a>] [<a href="/pubmed/25059390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25059390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.alyahyaee.2013.1467">Al-Yahyaee SA, Al-Kindi M, Jonghe PD, Al-Asmi A, Al-Futaisi A, Vriendt ED, Deconinck T, Chand P. Pelizaeus-Merzbacher-like disease in a family with variable phenotype and a novel splicing GJC2 mutation. <span><span class="ref-journal">J Child Neurol. </span>2013;<span class="ref-vol">28</span>:1467–73.</span> [<a href="/pubmed/23143715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23143715</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.biancheri.2013.34">Biancheri R, Rosano C, Denegri L, Lamantea E, Pinto F, Lanza F, Severino M, Filocamo M. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:34–9.</span> [<a href="/pmc/articles/PMC3533259/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3533259</span></a>] [<a href="/pubmed/22669416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22669416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.bugiani.2006.273">Bugiani M, Al Shahwan S, Lamantea E, Bizzi A, Bakhsh E, Moroni I, Balestrini MR, Uziel G, Zeviani M. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:273–9.</span> [<a href="/pubmed/16707726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16707726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.combes.2012.146">Combes P, Kammoun N, Monnier A, Gonthier-Gu&#x000e9;ret C, Giraud G, Bertini E, Chahnez T, Fakhfakh F, Boespflug-Tanguy O, Vaurs-Barri&#x000e8;re C. Relevance of GJC2 promoter mutation in Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">71</span>:146–8.</span> [<a href="/pubmed/21246605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21246605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.diekmann.2010.985">Diekmann S, Henneke M, Burckhardt BC, G&#x000e4;rtner J. Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:985–92.</span> [<a href="/pmc/articles/PMC2987409/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987409</span></a>] [<a href="/pubmed/20442743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20442743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.ferrell.2010.943">Ferrell RE, Baty CJ, Kimak MA, Karlsson JM, Lawrence EC, Franke-Snyder M, Meriney SD, Feingold E, Finegold DN. GJC2 missense mutations cause human lymphedema. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:943–8.</span> [<a href="/pmc/articles/PMC3032064/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3032064</span></a>] [<a href="/pubmed/20537300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20537300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.gotoh.2014.393">Gotoh L, Inoue K, Helman G, Mora S, Maski K, Soul JS, Bloom M, Evans SH, Goto YI, Caldovic L, Hobson GM, Vanderver A. GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">111</span>:393–8.</span> [<a href="/pmc/articles/PMC4183365/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4183365</span></a>] [<a href="/pubmed/24374284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24374284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.henneke.2008.748">Henneke M, Combes P, Diekmann S, Bertini E, Brockmann K, Burlina AP, Kaiser J, Ohlenbusch A, Plecko B, Rodriguez D, Boespflug-Tanguy O, G&#x000e4;rtner J. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:748–54.</span> [<a href="/pubmed/18094336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18094336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.henneke.2010.1785">Henneke M, Gegner S, Hahn A, Plecko-Startinig B, Weschke B, G&#x000e4;rtner J, Brockmann K. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">74</span>:1785–9.</span> [<a href="/pubmed/20513814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20513814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.kammoun_jellouli.2013.233">Kammoun Jellouli N, Salem IH, Ellouz E, Louhichi N, Tlili A, Kammoun F, Triki C, Fakhfakh F, et al.  Molecular confirmation of founder mutation c.-167A&#x0003e;G in Tunisian patients with PMLD disease. <span><span class="ref-journal">Gene. </span>2013;<span class="ref-vol">513</span>:233–8.</span> [<a href="/pubmed/23142375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23142375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.kim.2013.249">Kim MS, Gloor GB, Bai D. The distribution and functional properties of Pelizaeus-Merzbacher-like disease-linked Cx47 mutations on Cx47/Cx47 homotypic and Cx47/Cx43 heterotypic gap junctions. <span><span class="ref-journal">Biochem J. </span>2013;<span class="ref-vol">452</span>:249–58.</span> [<a href="/pubmed/23544880" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23544880</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.maglione.2010.1104">Maglione M, Tress O, Haas B, Karram K, Trotter J, Willecke K, Kettenmann H. Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. <span><span class="ref-journal">Glia. </span>2010;<span class="ref-vol">58</span>:1104–17.</span> [<a href="/pubmed/20468052" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20468052</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.menichella.2006.10984">Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E, Scherer SS, Paul DL. Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. <span><span class="ref-journal">J Neurosci. </span>2006;<span class="ref-vol">26</span>:10984–91.</span> [<a href="/pmc/articles/PMC6674647/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6674647</span></a>] [<a href="/pubmed/17065440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17065440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.meyer.2011.637">Meyer E, Kurian MA, Morgan NV, McNeill A, Pasha S, Tee L, Younis R, Norman A, van der Knaap MS, Wassmer E, Trembath RC, Brueton L, Maher ER. Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">104</span>:637–43.</span> [<a href="/pubmed/21959080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21959080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.odermatt.2003.4549">Odermatt B, Wellershaus K, Wallraff A, Seifert G, Degen J, Euwens C, Fuss B, B&#x000fc;ssow H, Schilling K, Steinh&#x000e4;user C, Willecke K. Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. <span><span class="ref-journal">J Neurosci. </span>2003;<span class="ref-vol">23</span>:4549–59.</span> [<a href="/pmc/articles/PMC6740816/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6740816</span></a>] [<a href="/pubmed/12805295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12805295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.orthmannmurphy.2007.13949">Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK. Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. <span><span class="ref-journal">J Neurosci. </span>2007;<span class="ref-vol">27</span>:13949–57.</span> [<a href="/pmc/articles/PMC6673504/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6673504</span></a>] [<a href="/pubmed/18094232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18094232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.orthmannmurphy.2009.426">Orthmann-Murphy JL, Salsano E, Abrams CK, Bizzi A, Uziel G, Freidin MM, Lamantea E, Zeviani M, Scherer SS, Pareyson D. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:426–38.</span> [<a href="/pmc/articles/PMC2640216/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2640216</span></a>] [<a href="/pubmed/19056803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19056803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.osaka.2010.250">Osaka H, Hamanoue H, Yamamoto R, Nezu A, Sasaki M, Saitsu H, Kurosawa K, Shimbo H, Matsumoto N, Inoue K. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Ann Neurol. </span>2010;<span class="ref-vol">68</span>:250–4.</span> [<a href="/pubmed/20695017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20695017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.parikh.2015.501">Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A, McNeill NH, Helman G, Simons C, Schmidt JL, Rizzo WB, Patterson MC, Taft RJ, Vanderver A, et al.  A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:501–15.</span> [<a href="/pmc/articles/PMC4390485/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4390485</span></a>] [<a href="/pubmed/25655951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25655951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.rash.2001.1983">Rash JE, Yasumura T, Dudek FE, Nagy JI. Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. <span><span class="ref-journal">J Neurosci. </span>2001;<span class="ref-vol">21</span>:1983–2000.</span> [<a href="/pmc/articles/PMC1804287/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1804287</span></a>] [<a href="/pubmed/11245683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11245683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.schlierf.2006.11">Schlierf B, Werner T, Glaser G, Wegner M. Expression of connexin47 in oligodendrocytes is regulated by the Sox10 transcription factor. <span><span class="ref-journal">J Mol Biol. </span>2006;<span class="ref-vol">361</span>:11–21.</span> [<a href="/pubmed/16822525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16822525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.shimojima.2013.123">Shimojima K, Tanaka R, Shimada S, Sangu N, Nakayama J, Iwasaki N, Yamamoto T. A novel homozygous mutation of GJC2 derived from maternal uniparental disomy in a female patient with Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">J Neurol Sci. </span>2013;<span class="ref-vol">330</span>:123–6.</span> [<a href="/pubmed/23684670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23684670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.simons.2013.767">Simons C, Wolf NI, McNeil N, Caldovic L, Devaney JM, Takanohashi A, Crawford J, Ru K, Grimmond SM, Miller D, Tonduti D, Schmidt JL, Chudnow RS, van Coster R, Lagae L, Kisler J, Sperner J, van der Knaap MS, Schiffmann R, Taft RJ, Vanderver A. A de novo mutation in the beta-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:767–73.</span> [<a href="/pmc/articles/PMC3644625/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3644625</span></a>] [<a href="/pubmed/23582646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23582646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.steenweg.2010.2971">Steenweg ME, Vanderver A, Blaser S, Bizzi A, de Koning TJ, Mancini GM, van Wieringen WN, Barkhof F, Wolf NI, van der Knaap MS. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:2971–82.</span> [<a href="/pmc/articles/PMC3589901/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3589901</span></a>] [<a href="/pubmed/20881161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20881161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.tress.2011.e1002146">Tress O, Maglione M, Zlomuzica A, May D, Dicke N, Degen J, Dere E, Kettenmann H, Hartmann D, Willecke K. Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002146.</span> [<a href="/pmc/articles/PMC3131295/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3131295</span></a>] [<a href="/pubmed/21750683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21750683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.uhlenberg.2004.251">Uhlenberg B, Schuelke M, R&#x000fc;schendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-Didinger G, Aksu F, Topalo&#x0011f;lu H, N&#x000fc;rnberg P, H&#x000fc;bner C, Weschke B, G&#x000e4;rtner J. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:251–60.</span> [<a href="/pmc/articles/PMC1216059/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1216059</span></a>] [<a href="/pubmed/15192806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15192806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.van_haren.2015.516">Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC, et al.  Consensus statement on preventive and symptomatic care of leukodystrophy patients. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:516–26.</span> [<a href="/pubmed/25577286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25577286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.wang.2010.236">Wang J, Wang H, Wang Y, Chen T, Wu X, Jiang Y. Two novel gap junction protein alpha 12 gene mutations in two Chinese patients with Pelizaeus-Merzbacher-like disease. <span><span class="ref-journal">Brain Dev. </span>2010;<span class="ref-vol">32</span>:236–43.</span> [<a href="/pubmed/19423250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19423250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.wasseff.2011.506">Wasseff SK, Scherer SS. Cx32 and Cx47 mediate oligodendrocyte:astrocyte and oligodendrocyte:oligodendrocyte gap junction coupling. <span><span class="ref-journal">Neurobiol Dis. </span>2011;<span class="ref-vol">42</span>:506–13.</span> [<a href="/pmc/articles/PMC3773476/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3773476</span></a>] [<a href="/pubmed/21396451" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21396451</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.willecke.2002.725">Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, G&#x000fc;ldenagel M, Deutsch U, S&#x000f6;hl G. Structural and functional diversity of connexin genes in the mouse and human genome. <span><span class="ref-journal">Biol Chem. </span>2002;<span class="ref-vol">383</span>:725–37.</span> [<a href="/pubmed/12108537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12108537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.wolf.2007.39">Wolf NI, Cundall M, Rutland P, Rosser E, Surtees R, Benton S, Chong WK, Malcolm S, Ebinger F, Bitner-Glindzicz M, Woodward KJ. Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. <span><span class="ref-journal">Neurogenetics. </span>2007;<span class="ref-vol">8</span>:39–44.</span> [<a href="/pubmed/16969684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16969684</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pmld1.REF.zittel.2012.2498">Zittel S, Nickel M, Wolf NI, Uyanik G, Gl&#x000e4;ser D, Ganos C, Gerloff C, M&#x000fc;nchau A, Kohlsch&#x000fc;tter A. "Pelizaeus-Merzbacher-like disease" presenting as complicated hereditary spastic paraplegia. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:2498–500.</span> [<a href="/pubmed/22833003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22833003</span></a>]</div></li></ul></div></div><div id="pmld1.Chapter_Notes"><h2 id="_pmld1_Chapter_Notes_">Chapter Notes</h2><div id="pmld1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 January 2019 (av) Revision: <a class="figpopup" href="/books/NBK470716/figure/pmld1.F1/?report=objectonly" target="object" rid-figpopup="figpmld1F1" rid-ob="figobpmld1F1">Figure 1</a> edited</div></li><li class="half_rhythm"><div>21 December 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>26 July 2016 (av) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK470716</span><span class="label">PMID: <a href="/pubmed/29276893" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29276893</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/parkinson-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pendred/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK470716&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK470716/?report=reader">PubReader</a></li><li><a href="/books/NBK470716/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK470716" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK470716" style="display:none" title="Cite this Page"><div class="bk_tt">Nahhas N, Conant A, Orthmann-Murphy J, et al. Pelizaeus-Merzbacher-Like Disease 1. 2017 Dec 21 [Updated 2019 Jan 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK470716/pdf/Bookshelf_NBK470716.pdf">PDF version of this page</a> (669K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pmld1.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pmld1.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pmld1.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pmld1.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pmld1.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pmld1.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pmld1.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pmld1.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pmld1.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pmld1.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pmld1.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57165[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GJC2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4486686" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4486686" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4486686" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4486686" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28541650" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SLC39A14 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SLC39A14 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tuschl K, Gregory A, Meyer E, Clayton PT, Hayflick SJ, Mills PB, Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30285346" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">NKX6-2</i>-Related Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">NKX6-2</i>-Related Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chelban V, Kaya N, Alkuraya F, Houlden H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301610" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Furukawa Y, Kish S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25719194" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TBC1D24</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TBC1D24</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mucha BE, Hennekam RCM, Sisodiya S, Campeau PM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29276893" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29276893" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d1c39a66ee2ba555213">Pelizaeus-Merzbacher-Like Disease 1 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Pelizaeus-Merzbacher-Like Disease 1 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:30:04-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A3D94E0402D1100000000044A0183&amp;ncbi_session=CE8A3D94E040D1C1_1098SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK470716%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK470716&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK470716/&amp;ncbi_pagename=Pelizaeus-Merzbacher-Like Disease 1 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A3D94E040D1C1_1098SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>